Control, compliance and access — from one platform.
Control and ROI for manufacturers. Compliance and transparency for government. Access and care for patients.
One platform that has to satisfy a regulator, a manufacturer and a patient at once.
Every aspect of SampliFi is designed to serve all three stakeholders simultaneously. Manufacturers get control and ROI. Government gets compliance and transparency. Patients get access and care.
True ROI visibility
Track every step from shipment to patient receipt. Measure impact on prescribing behavior with hard data, not estimates.
Single source oversight
All activities monitored through one centralized system of licensed providers. One dashboard, complete visibility.
Closed-loop data
Every action managed within a single, regulated network. Audit-ready records generated automatically at every stage.
Verified patient receipt
Know exactly when and if a patient receives the product, with a delivery record to match.
Reduce financial waste
Consignment inventory eliminates retail reimbursement costs, copay programs and traditional logistics overhead.
Customizable reporting
Granular reporting at each stage aligned to your KPIs and audit requirements, with geo-coded territory analysis.
HCP engagement renewed
A powerful new touchpoint for manufacturer sales teams — solving the "no-see physician" problem with real data.
Patient adherence built in
Two free fills place patients firmly on medication, and follow-up pharmacy consultations ensure understanding of treatment.
The same eight questions, answered two ways.
| Factor | Traditional sampling | SampliFi |
|---|---|---|
| Sample visibility | No visibility once samples leave the shipper | End-to-end tracking, manufacturer to patient |
| Patient proof | No proof samples ever reach patients | Patient receipt verified via FedEx |
| Compliance burden | High admin costs managing compliance | Automated compliance built into the system |
| Audit preparation | Manual audit prep is resource-intensive | Audit-ready records generated automatically |
| Workflow integration | E-prescribing bottlenecks and delays | Seamless e-prescribing integration, one click |
| Diversion risk | Diversion and security risks in supply chain | Closed loop prevents unauthorized access |
| ROI measurement | Impossible to quantify ROI | Granular ROI data at every stage |
| Coverage gaps | Coverage gaps for vacant territories | National e-prescribing, no territory gaps |
Swipe the table to compare
Where the program stands.
Program launch — system live
SampliFi officially launches with full e-prescribing integration, a live beta user cohort, and initial data showing strong patient engagement and compliance metrics.
Beta testing complete
Successful beta program with leading pharmaceutical manufacturers. All compliance requirements validated. System performance and data accuracy confirmed. Ready for commercial launch.
Regulatory clearances secured
FDA, DEA, state pharmacy boards and federal compliance authorities have cleared SampliFi for full operational deployment. The closed-loop system design meets all security and audit requirements.
Quantitative program results, real-world ROI data and additional case studies will be published here as they become available.
In the news.
SampliFi launches first real prescription program
A new system brings end-to-end visibility to pharmaceutical sampling for the first time. Press release and industry coverage.
Read on BioPharma DiveRegulatory approval granted for SampliFi
FDA and DEA provide final clearance for the closed-loop pharmaceutical prescription system. Industry experts celebrate the breakthrough.
Read on PharmaVoicePartner testimonials
We're collecting feedback from beta program participants and early adopters. Real-world impact stories from leading pharmaceutical manufacturers will be published here.
Join the future of pharmaceutical access.
Whether you're a government agency, a pharmaceutical manufacturer or a healthcare organization — SampliFi is built for you.